OCUGEN, INC. Share-based Payment Arrangement, Noncash Expense
OCUGEN, INC. (OCGN) reported Share-based Payment Arrangement, Noncash Expense of $144.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2019-08-09
- OCUGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $37.00K, a 90.91% decline year-over-year.
- OCUGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $107.00K, a 73.45% decline year-over-year.
- OCUGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2018-12-31 was $376.00K, a 10.59% increase year-over-year.
- OCUGEN, INC. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $439.00K, a 18.97% increase year-over-year.
- OCUGEN, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $1.63M, a 3.31% increase from fiscal 2017.
- OCUGEN, INC. share-based payment arrangement, noncash expense for fiscal 2017 was $1.57M, a 1.61% increase from fiscal 2016.
- OCUGEN, INC. share-based payment arrangement, noncash expense for fiscal 2016 was $1.55M, a 26.06% increase from fiscal 2015.
- OCUGEN, INC. share-based payment arrangement, noncash expense for fiscal 2015 was $1.23M, a 124.50% increase from fiscal 2014.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $144.00K 10-Q · filed 2019-08-09 | $520.00K derived: sum of 3 quarters · filed 2019-08-09 | $959.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | $107.00K 10-Q · filed 2019-05-15 | $483.00K derived: sum of 2 quarters · filed 2019-05-15 | $922.00K derived: sum of 3 quarters · filed 2019-05-15 | $1.33M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $815.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.22M derived: sum of 3 quarters · filed 2019-08-09 | $1.63M 10-K · filed 2019-03-22 |
| 2018-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $846.00K derived: sum of 2 quarters · filed 2019-08-09 | $1.25M 10-Q · filed 2018-11-08 | $1.59M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-06-30 | $407.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $810.00K 10-Q · filed 2019-08-09 | $1.15M derived: sum of 3 quarters · filed 2019-08-09 | $1.52M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $403.00K 10-Q · filed 2019-05-15 | $743.00K derived: sum of 2 quarters · filed 2019-05-15 | $1.11M derived: sum of 3 quarters · filed 2019-05-15 | $1.48M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $709.00K derived: sum of 2 quarters · filed 2019-03-22 | $1.08M derived: sum of 3 quarters · filed 2019-03-22 | $1.57M 10-K · filed 2019-03-22 |
| 2017-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $741.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.23M 10-Q · filed 2018-11-08 | $1.70M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $864.00K 10-Q · filed 2018-08-09 | $1.33M derived: sum of 3 quarters · filed 2018-08-09 | $1.76M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $492.00K 10-Q · filed 2018-05-10 | $960.00K derived: sum of 2 quarters · filed 2018-05-10 | $1.39M derived: sum of 3 quarters · filed 2018-05-10 | $1.73M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $901.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.24M derived: sum of 3 quarters · filed 2018-03-15 | $1.55M 10-K · filed 2018-03-15 |
| 2016-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $769.00K derived: sum of 2 quarters · filed 2017-11-09 | $1.08M 10-Q · filed 2017-11-09 | $1.45M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $336.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $647.00K 10-Q · filed 2017-08-10 | $1.02M derived: sum of 3 quarters · filed 2017-08-10 | $1.38M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $311.00K 10-Q · filed 2017-05-11 | $685.00K derived: sum of 2 quarters · filed 2017-05-11 | $1.05M derived: sum of 3 quarters · filed 2017-05-11 | $1.30M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $736.00K derived: sum of 2 quarters · filed 2017-03-16 | $993.00K derived: sum of 3 quarters · filed 2017-03-16 | $1.23M 10-K · filed 2017-03-16 |
| 2015-09-30 | $362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $619.00K derived: sum of 2 quarters · filed 2016-11-10 | $854.00K 10-Q · filed 2016-11-10 | $1.04M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $257.00K 10-Q · filed 2015-08-12 | $492.00K 10-Q · filed 2016-08-11 | $683.00K derived: sum of 3 quarters · filed 2016-05-12 | $851.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-03-31 | $235.00K 10-Q · filed 2016-05-12 | $426.00K derived: sum of 2 quarters · filed 2016-05-12 | $594.00K derived: sum of 3 quarters · filed 2016-05-12 | $706.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $359.00K derived: sum of 2 quarters · filed 2016-03-10 | $471.00K derived: sum of 3 quarters · filed 2016-03-10 | $547.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $168.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $280.00K derived: sum of 2 quarters · filed 2015-11-12 | $356.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $112.00K 10-Q · filed 2015-08-12 | $188.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $76.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |